The cytotoxicity and genotoxicity of okadaic acid are cell-line dependent

Ghada Souid-Mensi1, Serge Moukha, Theophile A Mobio

  • 1Laboratory of Toxicology and Applied Hygiene, University Victor Segalen Bordeaux, 146 rue Léo-Saignat, Bordeaux, France.

Insights

Okadaic acid (OA) causes cell death, but its genotoxicity is cell-type and concentration dependent. HepG-2 cells showed p53-dependent apoptosis and DNA damage, unlike other cell lines.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Cell Biology

Background:

  • Okadaic acid (OA) is a marine toxin from dinoflagellates responsible for diarrhoeic shellfish poisoning (DSP).
  • Controversies exist regarding the in vitro genotoxicity of Okadaic acid.
  • Understanding OA's cellular effects is crucial for human health risk assessment.

Purpose of the Study:

  • To investigate the genotoxicity and cellular response of Okadaic acid in different cell lines.
  • To resolve conflicting data on OA's genotoxic potential.
  • To elucidate the mechanisms of OA-induced cell death and DNA damage.

Main Methods:

  • Utilized DNA damage detection tests (3D DNA repair: NER, BER).
  • Assessed apoptosis via caspase-3 activation.
  • Measured cytotoxicity using neutral red (NR) and lactate dehydrogenase (LDH) release assays.
  • Tested OA on DOK, Caco-2 (p53 deficient), HepG-2, and C6 glioma cells.

Main Results:

  • Okadaic acid induced necrosis in DOK cells at 10nM, with minimal effect in HepG-2 cells.
  • Apoptosis and DNA damage, dependent on the p53 gene, were observed exclusively in HepG-2 cells at low OA concentrations.
  • HepG-2 cells were most sensitive to OA (10-50nM) based on NR uptake.
  • DNA damage was only detected in HepG-2 cells using the 3D DNA repair test.

Conclusions:

  • Okadaic acid's genotoxicity is significantly dependent on cell type and OA concentration.
  • HepG-2 cells exhibit a p53-mediated apoptotic response to OA, explaining previously controversial findings.
  • The study clarifies OA's genotoxic profile, highlighting cell-specific susceptibility.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...